Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001246360-12-003626)

Filing Details

Accession Number:: 0001246360-12-003626
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-08-27 17:40:11
Reporting Period:: 2012-08-23

Filing Date:: 2012-08-27
Accepted Time:: 2012-08-27 17:40:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
859368	Medicis Pharmaceutical Corp	MRX	Pharmaceutical Preparations (2834)	521574808

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1189792	S Peter Knight	7720 N. Dobson Rd. Scottsdale AZ 85256		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-08-23	3,500	$20.44	16,032	No	4	M	Direct
Common Stock	Disposition	2012-08-23	3,500	$32.16	12,532	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Employee Director Option	Disposition	2012-08-23	3,500	$0.00	3,500	$20.44

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2003-09-30	2012-09-30	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.151 to $32.161, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.